Alpharma, Biotechnology Investments Ltd. deal

Alpharma's Animal Health division acquired from Biotechnology Investments an exclusive worldwide license to Reporcin porcine somatotropin for use in producing lean meat in swine. Alpharma also acquired Southern Cross Biotech Pty Ltd. (Toorak, Australia), the manufacturer and marketer of Reporcin, from Biotechnology Investments. ...